Breaking News

Credit Suisse Accuses Trader of Sharing Client Info With Husband
Tweet TWEET

Valent BioSciences Corporation Issued a US Patent on the use of S-Abscisic Acid in Human and Animal Health

  Valent BioSciences Corporation Issued a US Patent on the use of S-Abscisic
  Acid in Human and Animal Health

Illinois biotechnology company patent claims uses relating to certain
pharmaceutical and nutraceutical applications of S-ABA.

Business Wire

LIBERTYVILLE, Ill. -- September 17, 2013

Valent BioSciences Corporation (VBC), a worldwide leader in the discovery,
development, manufacturing, and commercialization of biorational products,
announced today it has been awarded Patent No. 8,536,224 by the United States
Patent and Trade Office for the therapeutic use of S-Abscisic Acid (S-ABA) and
certain derivatives in select human and animal health applications. The patent
includes five claims relating to methods for treating attention deficit
disorder, treating prostate enlargement, increasing post-natal weight gain,
increasing post-natal survival rates, and increasing immunological function.

As the only commercial scale producer and marketer of S-ABA products in the
world, the patent further strengthens VBC’s global position with this
important molecule. Abscisic Acid is a naturally occurring substance found in
all plants, including fruits and vegetables. It is actively involved in a
variety of important plant growth processes including dormancy, fruit
ripening, fruit set, fruit coloring, abscission, germination, and response to
stress conditions. VBC currently holds more than 40 ABA-related patents and
sells commercial S-ABA products into agricultural markets around the globe.

“VBC has been researching ABA globally in multiple agricultural and
non-agricultural applications since the early 2000s,” said Dr. Warren Shafer,
Vice President of Research and Development for VBC. “Since that time, we have
developed a robust and proprietary data package that includes a wide array of
efficacy and toxicology results. We consider S-ABA to be a franchise molecule
and have strategic interests in seeing this molecule expand into markets
beyond crop production. This patent is just one result of that work.”

Shafer notes that VBC has several additional ABA-related patent applications
pending both in the US and around the world, and that VBC is actively seeking
parties potentially interested in further commercializing this technology.
Inquiries can be submitted through the company’s website at
www.valentbiosciences.com.

About Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of
Tokyo-based Sumitomo Chemical Co., Ltd. Valent BioSciences is the worldwide
leader in the development, manufacturing and commercialization of biorational
products, with sales in 95 countries around the world. Valent BioSciences is
an ISO 9001:2008 Certified Company. For additional information, visit the
company’s website at www.valentbiosciences.com.

Contact:

Valent BioSciences Corporation
Rick Melnick, 847-968-4780
rick.melnick@valentbiosciences.com
 
Press spacebar to pause and continue. Press esc to stop.